These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1340777)

  • 1. Release of vasoactive substances during cardiopulmonary bypass.
    Downing SW; Edmunds LH
    Ann Thorac Surg; 1992 Dec; 54(6):1236-43. PubMed ID: 1340777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deterioration of body oxygen metabolism by vasodilator and/or vasoconstrictor administration during cardiopulmonary bypass.
    Sato K; Sogawa M; Namura O; Hayashi J
    ASAIO J; 2006; 52(1):96-9. PubMed ID: 16436897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of vasoactive substances on vascular smooth muscle of various body parts in monkeys].
    Fukushima S; Ohashi T
    Nihon Heikatsukin Gakkai Zasshi; 1989 Dec; 25(6):297-9. PubMed ID: 2518459
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood-surface interactions during cardiopulmonary bypass.
    Edmunds LH
    J Card Surg; 1993 May; 8(3):404-10. PubMed ID: 8507971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction in cerebral microcirculation during hypothermic cardiopulmonary bypass in newborn lambs.
    Wagerle LC; Russo P; Dahdah NS; Kapadia N; Davis DA
    J Thorac Cardiovasc Surg; 1998 May; 115(5):1047-54. PubMed ID: 9605074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive molecules as regulators of cell growth.
    Wolf G
    Exp Nephrol; 1994; 2(2):61-2. PubMed ID: 8082017
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormonal regulation of glomerular filtration.
    Kon V; Ichikawa I
    Annu Rev Med; 1985; 36():515-31. PubMed ID: 2986529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrovascular relaxation responses to endothelium-dependent and -independent vasodilators after normothermic and hypothermic cardiopulmonary bypass in the rabbit.
    Hindman BJ; Enomoto S; Dexter F; Bates JN; Aldape G; Cutkomp J; Smith T
    Anesthesiology; 1998 Jun; 88(6):1614-23. PubMed ID: 9637656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cardiopulmonary bypass on eicosanoid metabolism during pediatric cardiovascular surgery.
    Greeley WJ; Bushman GA; Kong DL; Oldham HN; Peterson MB
    J Thorac Cardiovasc Surg; 1988 May; 95(5):842-9. PubMed ID: 3283461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass.
    Gaies MG; Gurney JG; Yen AH; Napoli ML; Gajarski RJ; Ohye RG; Charpie JR; Hirsch JC
    Pediatr Crit Care Med; 2010 Mar; 11(2):234-8. PubMed ID: 19794327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of isolated cerebral arteries to vasoactive agents.
    White RP
    Neurosurg Clin N Am; 1990 Apr; 1(2):401-15. PubMed ID: 2136151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vasoactive substances and pulmonary shunt ratios].
    Okada K
    Kokyu To Junkan; 1977 Dec; 25(12):1074. PubMed ID: 601344
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces.
    Busse R; Fleming I
    Trends Pharmacol Sci; 2003 Jan; 24(1):24-9. PubMed ID: 12498727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant aprotinin on postoperative blood loss and coronary vascular function in a canine model of cardiopulmonary bypass.
    Veres G; Radovits T; Schultz H; Lin LN; Hütter J; Weigang E; Szabolcs Z; Szabó G
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):340-5. PubMed ID: 17500000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory response to cardiopulmonary bypass.
    Edmunds LH
    Ann Thorac Surg; 1998 Nov; 66(5 Suppl):S12-6; discussion S25-8. PubMed ID: 9869435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced skin reactivity to vasoconstrictor and vasodilator substances in atopic eczema.
    Zirbs M; Reindel U; Hermann K; Church MK; Behrendt H; Ring J; Brockow K
    Eur J Dermatol; 2013; 23(6):812-9. PubMed ID: 24201043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The behavior of fat and carbohydrate metabolites following administration of vasoactive substances].
    Hammerl H; Kränzl C; Pichler O; Studlar M
    Verh Dtsch Ges Inn Med; 1967; 73():793-7. PubMed ID: 5591842
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered response to vasopressors before and during cardiopulmonary bypass.
    Baraka A
    Anesthesiology; 1989 Jun; 70(6):1023-4. PubMed ID: 2729622
    [No Abstract]   [Full Text] [Related]  

  • 19. Mesenteric endothelial dysfunction in a cardiopulmonary bypass rat model: the effect of diabetes.
    Le Guillou V; Tamion F; Jouet I; Richard V; Mulder P; Bessou JP; Doguet F
    Diab Vasc Dis Res; 2012 Oct; 9(4):270-9. PubMed ID: 22278737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled prostacyclin reduces cardiopulmonary bypass-induced pulmonary endothelial dysfunction via increased cyclic adenosine monophosphate levels.
    Fortier S; DeMaria RG; Lamarche Y; Malo O; Denault A; Desjardins F; Carrier M; Perrault LP
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):109-16. PubMed ID: 15224029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.